• Reducing Disparities in Genetic Testing: A Framework Using the Example of Cystic Fibrosis

    Jul 26 | Diagnostics World News | The sources of health disparities are complex, and diagnostic testing is just one waystation on what is often an exhausting trek for many patients and their families. But today’s genetic tests may not be useful across ancestral groups. More

  • Sema4 Begins Trading, Eyes Healthcare Partnerships, Liquid Biopsy

    Jul 23 | Diagnostics World News | The board members of both Sema4 and CM Life Sciences voted this week to approve the special purpose acquisition company. The resulting combined company, Sema4 Holdings Corp, will commence trading of its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW” today or Monday. More

  • PacBio Acquires Short-Read Sequencer Omniome for $800M

    Jul 20 | Diagnostics World News | Pacific Biosciences announced this morning that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy. More

  • Inflammatory Clock Measures ‘Universal’ Hallmark Of Aging

    Jul 15 | Diagnostics World News | Systemic chronic inflammation—a universally strong signal of ill health associated with all nine hallmarks of aging and diseases that collectively represent the leading causes of disability and mortality worldwide—can now be measured by an inflammatory clock of aging (iAge) developed by investigators at the Stanford University School of Medicine and the Buck Institute for Research on Aging. It is the first “actionable clock” that predicts multimorbidity, frailty, immunological health, and chronic diseases of aging. More

  • COVID-19 Diagnostics Commons Looks to Democratize Knowledge, Help Employers Address Challenges of Bringing Workers Back

    Jul 13 | Diagnostics World News | Employers are testing for COVID-19 at noticeably higher levels in 2021 compared to late 2020, according to findings from a global business survey conducted by Arizona State University's College of Health Solutions and the World Economic Forum, along with support from the Rockefeller Foundation. Responses came from over 1,100 companies spanning more than 20 industry sectors and over 30 countries. More

  • A Glimpse Into the Future Of Infectious Disease Diagnostics

    Jul 06 | Diagnostics World News | A “silver lining” of COVID-19 is that it has ushered in a new era of diagnostic innovation within test manufacturing facilities and clinical and public health laboratories, producing in 18 months what would be a decade’s worth of progress in non-pandemic times. Near-universal focus on one common problem created new ways to work together, overcome gaps in resources, and develop novel point-of-care testing methods under intense time pressures, as will be explored during the upcoming Next-Gen Dx Summit. More

  • Brain Age Prediction Model Distinguishes Normal Cognitive Impairment From Early AD

    Jul 06 | Diagnostics World News | A team of researchers from Beijing Normal University in China has developed an artificial intelligence-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment. They hope the model will help earlier detection of cognitive impairment at an individual level. More

  • Follow the Money: Microbiome-Based Diagnostics

    Jul 02 | Diagnostics World News | Insilico Medicine closes a Series C for AI-powered drug discovery, while other investments fuel microbiome-based diagnostics. More

  • New Diagnostic Partnerships, Products, and COVID-19 Testing Updates

    Jun 29 | Diagnostics World News | What’s next for Biogen and Eisai; COVID updates from Thermo Fisher, New England Biolabs, and OraSure; new products from QIAGEN, InterVenn, Nuvo Group and more. More

  • White-Box Algorithms Could Invite More EEG-Based Monitoring In The OR

    Jun 23 | Diagnostics World News | Only about a quarter of anesthesiologists delivering anesthesia to patients during surgery are monitoring unconsciousness using electroencephalography (EEG), the recording of neural activity via electrodes on the scalp. A new company spun out of MIT and MGH hopes to change that. More
View more articles

 
DXX-Industry-spotlight

Acrobiosystems

Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.